3 completed, 1 unknown. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 3, Unknown 1 |
Follow Androgen Antagonists: new trials by email Literature Review of Androgen Antagonists trials Research Report on Androgen Antagonists
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients Leuprorelin, Goserelin, Triptorelin - Prostatic Neoplasms | Phase 4 | Unknown | Wonju Severance Christian Hospital | 164 | 2020-01-23 | 2021-07-29 |
| A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC) Apalutamide, Placebo, Androgen-deprivation Therapy (ADT) - Prostatic Neoplasms | Phase 4 | Completed | Janssen Research & Development, LLC | 75 | 2019-12-17 | 2026-07-30 |
| A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy Enzalutamide, Androgen deprivation therapy (ADT) - Metastatic Castration Resistant Prostate Cancer | Phase 4 | Completed | Astellas Pharma Inc | 52 | 2018-09-19 | 2026-06-24 |
| Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer Enzalutamide, Flutamide, Androgen deprivation therapy - Prostate Cancer | Phase 4 | Completed | Astellas Pharma Inc | 206 | 2016-11-02 | 2024-12-09 |
Astellas Pharma Inc (2) · Janssen Research & Development, LLC (1) · Wonju Severance Christian Hospital (1)
China (1) · India (1) · Japan (1) · South Korea (1)